Index lesion dosimetry for (177)Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer Meeting Abstract

  

Authors:	Grkovski, M.; O'Donoghue, J.; Imber, B.; Andl, G.; Tu, C.; Lafontaine, D.; Schwartz, J.; Thor, M.; Zelefsky, M.; Humm, J.; Bodei, L.
Abstract Title:	Index lesion dosimetry for (177)Lu-PSMA-617 radiopharmaceutical therapy combined with stereotactic body radiotherapy in patients with oligometastatic castration-sensitive prostate cancer
Meeting Title:	2023 SNMMI Annual Meeting
Journal Title:	Journal of Nuclear Medicine
Volume:	64
Issue:	Suppl. 1
Meeting Dates:	2023 Jun 24-27
Meeting Location:	Chicago, IL
ISSN:	0161-5505
Publisher:	Society of Nuclear Medicine
Date Published:	2023-06-01
Language:	English
ACCESSION:	WOS:001109210202025
PROVIDER:	wos
Notes:	Meeting Abstract: P991-- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/214471